Zymeworks at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Zymeworks brings 3 presentations to PEGS Europe 2026 in Lisbon. Its program centres on conditional and multispecific designs, from tumour-targeted masked cytokines to a T cell engager platform with conditional CD28 co-stimulation. It also covers a molecule hitting the IL-4Ra and IL-33 pathways together to damp autoimmune inflammation.

OrganizationPEGS Europe 2026 Attendance
zymeworks.com
Biotech
Clinical-stage biotech developing multispecific antibodies and antibody-drug conjugates for cancer and inflammatory diseases; created the Azymetric bispecific platform.
Talk
Tue Nov 17
2:05pm–2:35pm
Next-Generation Tumour-Targeted Masked Cytokines for Enhanced Tolerability and Localised Anti-Tumour Activity
Safety and Efficacy of Bispecific and Multispecific Antibodies
Talk
Tue Nov 17
2:05pm–2:35pm
Talk
Wed Nov 18
9:00am–9:30am

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Zymeworks

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction